Boditech Med Inc. (KOSDAQ:206640)
10,400
-110 (-1.05%)
Jun 10, 2026, 3:30 PM KST
Boditech Med Revenue
Boditech Med had revenue of 42.85B KRW in the quarter ending March 31, 2026, with 9.58% growth. This brings the company's revenue in the last twelve months to 165.84B, up 15.03% year-over-year. In the year 2025, Boditech Med had annual revenue of 162.09B with 17.32% growth.
Revenue (ttm)
165.84B
Revenue Growth
+15.03%
P/S Ratio
1.28
Revenue / Employee
306.54M
Employees
541
Market Cap
211.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 162.09B | 23.93B | 17.32% |
| Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
| Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
| Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
| Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 952.66B |
| Suheung | 743.02B |
| Daewon Pharmaceutical | 605.66B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 266.19B |
| JW Lifescience | 252.72B |
| Korea United Pharm | 161.44B |
| Yungjin Pharm. | 158.79B |